Epidemiology of Chlamydia trachomatis endocervical infection in a previously unscreened population in Rome, Italy, 2000 to 2009

Eurosurveillance

Volumn 17, Issue 25, 2012, Pages

  Marcone, V ^a   Recine, N ^b   Gallinelli, C ^a   Nicosia, R ^a   Lichtner, M ^b   Degener, A M ^a   Chiarini, F ^a   Calzolari, E ^b   Vullo, V ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIAL URETHRITIS; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DRUG USE; FEMALE; GONORRHEA; HIGH RISK POPULATION; HUMAN; ITALY; NEISSERIA GONORRHOEAE; PAPILLOMAVIRUS INFECTION; PREGNANCY DISORDER; PREVALENCE; QUESTIONNAIRE; SEXUAL BEHAVIOR; SMOKING; TRICHOMONIASIS; UTERINE CERVICITIS; WART VIRUS;

EID: 84862865660     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Paavonen J. Chlamydia trachomatis infections of the female genital tract: state of the art. Ann Med. 2012;44(1):18-28.
2. World Health Organization (WHO). Prevalence and incidence of selected sexually transmitted infections, Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis: methods and results used by WHO to generate 2005 estimates. Geneva: WHO; 2011. Available from:http://whqlibdoc.who.int/publications/2011/9789241502450_eng.pdf
3. van de Laar MJ, Morré SA. Chlamydia: a major challenge for public health. Euro Surveill. 2007;12(10):735. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=735
4. Wilson JS, Honey E, Templeton A, Paavonen J, Mårdh PA, Stray-Pedersen B, et al. A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update. 2002;8:385-94.
5. European Centre for Disease Prevention and Control (ECDC). Chlamydia control in Europe. ECDC Guidance. Stockholm: ECDC; 2009. Available from:http://ecdc.europa.eu/en/publications/Publications/0906_GUI_Chlamydia_Control_in_Europe.pdf
6. European Centre for Disease Prevention and Control (ECDC). Sexually transmitted infections in Europe, 1990-2009. Stockholm: ECDC; 2011. Available from:http://ecdc.europa.eu/en/publications/Publications/110526_SUR_STI_in_Europe_1990-2009.pdf
7. European Centre for Disease Prevention and Control (ECDC). Review of Chlamydia control activities in EU countries. Stockholm, May 2008. Technical Report. Stockholm: ECDC; 2008. Available from:http://ecdc.europa.eu/en/publications/publications/0805_ter_review_of_chlamydia_control_activities.pdf
8. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis. 2010;201 Suppl 2:S134-55.
9. Baud D, Regan L, Greub G. Emerging role of Chlamydia and Chlamydia-like organisms in adverse pregnancy outcomes. Curr Opin Infect Dis. 2008;21(1):70-6.
10. Wagenlehner FM, Naber KG, Weidner W. Chlamydial infections and prostatitis in men. BJU Int. 2006;97(4):687-90.
11. Eley A, Pacey AA, Galdiero M, Galdiero M, Galdiero F. Can Chlamydia trachomatis directly damage your sperm? Lancet Infect Dis. 2005;5(1):53-7.
12. Gonçalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev. 2002;8(1):3-13.
13. Diemer T, Ludwig M, Huwe P, Hales DB, Weidner W. Influence of urogenital infection on sperm function. Curr Opin Urol. 2000;10(1):39-44.
14. Paavonen J, Eggert-Kruse W. Chlamydia trachomatis: impact on human reproduction. Hum Reprod Update. 1999;5(5):433-47.
15. Land JA, Van Bergen JE, Morré SA, Postma MJ. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Hum Reprod Update. 2010;16 (2):189-204.
16. Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010;59(RR-12):1-110.
17. Sutton MY, Sternberg M, Zaidi A, St Louis ME, Markowitz LE. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001. Sex Transm Dis. 2005;32(12):778-84.
18. Chandra A, Martinez GM, Mosher WD, Abma JC, Jones J. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital Health Stat 23. 2005;(25):1-160.
19. French CE, Hughes G, Nicholson A, Yung M, Ross JD, Williams T, et al. Estimation of the rate of pelvic inflammatory disease diagnoses: trends in England, 2000-2008. Sex Transm Dis. 2011;38(3):158-62.
20. Bender N, Herrmann B, Andersen B, Hocking JS, van Bergen J, Morgan J, et al. Chlamydia infection, pelvic inflammatory disease, ectopic pregnancy and infertility: cross-national study. Sex Transm Infect. 2011;87(7):601-8.
21. Determinants of cervical Chlamydia trachomatis infection in Italy. The Italian MEGIC Group. Genitourin. Med. 1993;69(2):123-5.
22. Giuliani M, Suligoi B, the STD Surveillance Working Group. Sentinel surveillance of sexually transmitted diseases in Italy. Euro Surveill. 1998;3(6):97. Available from:http://www.eurosurveillance.org/viewarticle.aspx?articleid=97
23. Ministry of Health. Lo stato di salute delle donne in Italia. [Women's health status in Italy]. Rome: Ministry of Health; March 2008. Italian. Available from:http://www.ministerosalute.it/imgs/C_17_pubblicazioni_764_allegato.pdf
24. World Medical Association (WMA). Declaration of Helsinki. WMA General Assembly, Seoul, South Korea, October 2008. World Medical Journal. 2008;54(4):122-5. Available from:http://www.wma.net/en/30publications/20journal/pdf/wmj20.pdf
25. Italian Data Protection Authority. Linee guida in tema di fascicolo sanitario elettronico e di dossier sanitario. [Guidelines on the Electronic Health Record and the Health File]. Gazzetta Ufficiale-Serie Generale. 3 Aug 2009;178. Rome: Istituto Poligrafico e Zecca dello Stato. Italian. Summary available from:http://www.guritel.it/free-sum/ARTI/2009/08/03/sommario.html; (English version available from:http://www.garanteprivacy.it/garante/doc.jsp?ID=1672821).
26. Donders GG. Definition and classification of abnormal vaginal flora. Best Pract Res Clin Obstet Gynaecol. 2007;21(3):355-73.
27. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med.1983;74(1):14-22.
28. Health Protection Agency (HPA). Chlamydia trachomatis infection-testing by nucleic acid amplification tests (NAATs). UK standards for microbiology investigations. Virology. 37(3). London: HPA; 25 May 2012. Available from: http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1316425069287
29. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989;7(17):209-14.
30. Barbé, G, Babolat M, Boeufgras JM, Monget D, Freney J. Evaluation of API NH, a new 2-hour system for identification of Neisseria and Haemophilus species and Moraxella catarrhalis in a routine clinical laboratory. J Clin Microbiol. 1994;32(1):187-9.
31. Franceschi S, Smith JS, van den Brule A, Herrero R, Arslan A, Ahn PT, et al. Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. Sex Transm Dis. 2007;34(8):563-9.
32. Griffiths V, Cheung WH, Carlin EM, Ahmed-Jushuf I. Incidence of concurrent sexually transmitted infections in patients with genital warts. Int J STD AIDS. 2006;17(6):413-4.
33. Lo M, Reid M, Brokenshire M. Epidemiological features of women with trichomoniasis in Auckland sexual health clinics: 1998-99. New Zeal Med J. 2002;115(1159):U119.
34. Gall SA. Oral contraceptives and Chlamydia infections. JAMA. 1986;255(1):38-9.
35. Oh MK, Feinstein RA, Soileau EJ, Cloud GA, Pass RF. Chlamydia trachomatis cervical infection and oral contraceptive use among adolescent girls. J Adolesc Health Care. 1989;10(5):376-81.
36. Corbeto EL, Lugo R, Martró E, Falguera G, Ros R, Avecilla A, et al. Epidemiological features and determinants for Chlamydia trachomatis infection among women in Catalonia, Spain. Int J STD AIDS. 2010;21(10):718-22.
37. Warner L, Stone KM, Macaluso M, Buehler JW, Austin HD. Condom use and risk of gonorrhea and Chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis. 2006;33(1):36-51.
38. Ripa T, Nilsson PA. A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests. Euro Surveill. 2006; Euro Surveill. 11(45):3076. Available from:http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=3076
39. Herrmann B. A new genetic variant of Chlamydia trachomatis. Sex Transm Infect. 2007; 83(4):253-4.